Clinical Trial Update: Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing [NA]

View source ↗

Summary

The TRIAL program (Tools for Reducing Inequity in Acute Leukemia) is in beta testing and currently recruiting, sponsored by the Dana-Farber Cancer Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Leukemia, Leukemia | NA | Status: RECRUITING